01 1Teva Pharmaceutical Industries
01 1QUETIAPINE FUMARATE
01 1Israel
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-07-12
Pay. Date : 2023-06-13
DMF Number : 37041
Submission : 2023-06-15
Status : Active
Type : II
20
Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is QUETIAPINE FUMARATE, with a corresponding US DMF Number 37041.
Remarkably, this DMF maintains an Active status since its submission on June 15, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 12, 2023, and payment made on June 13, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
